Pasithea Therapeutics (KTTAW) SEC Filings & 10K Form $0.02 0.00 (-17.28%) As of 05/2/2025 09:30 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Recent Pasithea Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/01/20258:27 AMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form S-1Registration statement under Securities Act of 1933 03/24/20253:55 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/06/20258:55 PMPasithea Therapeutics Corp. (Subject)Pasithea Therapeutics (Subject)STEINMAN LAWRENCE (Filed by)Form SCHEDULE 13D/A02/14/20254:50 PMARMISTICE CAPITAL, LLC (Filed by)Pasithea Therapeutics Corp. (Subject)Pasithea Therapeutics (Subject)Form SCHEDULE 13G/A11/26/20244:00 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/26/20244:01 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 424B511/13/20243:30 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/14/202411:15 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form EFFECT10/11/20244:12 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 424B309/30/20243:49 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/26/20247:45 AMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/26/20244:00 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/14/20244:25 PMNovak Alfred J (Reporting)Pasithea Therapeutics Corp. (Issuer)Pasithea Therapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 05/28/20248:00 AMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form DEF 14A05/28/20248:05 AMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form ARS05/14/20244:15 PMPasithea Therapeutics Corp. (Filer)Pasithea Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ATNFW SEC Filings LBPSW SEC Filings AEHAW SEC Filings AIMDW SEC Filings ALVOW SEC Filings ACABW SEC Filings BFRIW SEC Filings BTMDW SEC Filings BCTXW SEC Filings CELUW SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:KTTAW) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KTTAW Stock Free KTTAW Stock Alerts